Generic patch tested for depression treatment
NCT ID NCT06607744
Summary
This small study aimed to see if a new generic version of a selegiline skin patch gets into the bloodstream the same way as the existing brand-name patch (EMSAM®). It involved 12 healthy adults who each wore both patches at different times. Researchers measured drug levels in the blood and checked for skin irritation to compare the two versions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Ampang
Ampang, Selangor, 68000, Malaysia
-
Sarawak General Hospital
Samoran, Sarawak, 94300, Malaysia
Conditions
Explore the condition pages connected to this study.